Ra Pharmaceuticals Inc (RARX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

87 CAMBRIDGE PARK DRIVE CAMBRIDGE, MA 02140

Ra Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company offers drugs for the treatment of cancer, inflammation and autoimmune disease, diabetes, and cardiovascular. Ra Pharmaceuticals conducts its business in the United States.

Data as of 2019-12-03 03:55:57 -0500
Market Cap2.204 Billion Shares Outstanding47.146 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-1.989
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low47.35 / 14.36 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from RARX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RARX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RARX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LUBNER DAVID CHARLES EXECUTIVE VP AND CFO

  • Officer
No longer subject to file 2020-04-02 0

TRECO DOUGLAS A PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2020-04-02 0

SHAH RAJEEV M.

  • Director
  • 10% Owner
No longer subject to file 2020-04-02 0

HEFT ROBERT

  • Director
No longer subject to file 2020-04-02 0

FARZANEH-FAR RAMIN CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2020-04-02 0

READ SIMON CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2020-04-02 0

PEARSON TIMOTHY R

  • Director
No longer subject to file 2020-04-02 0

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
No longer subject to file 2020-04-02 0

MATHERS EDWARD T

  • Director
No longer subject to file 2020-04-02 0

KING JOHN C CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2020-04-02 0

BRENNAN AOIFE

  • Director
No longer subject to file 2020-04-02 0

CUMBO ALEXANDER

  • Director
No longer subject to file 2020-04-02 0

RICARDO ALONSO SEE REMARKS

  • Officer
No longer subject to file 2020-04-02 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BASKETT FOREST

KERINS PATRICK J

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2020-04-02 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

MOTT DAVID M

SANDELL SCOTT D

  • 10% Owner
6,135,234 2018-12-14 0

BISGAARD PETER

  • Director
0 2018-06-28 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BARRETT M JAMES

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

MOTT DAVID M

SANDELL SCOTT D

VISWANATHAN RAVI

  • 10% Owner
5,490,073 2018-02-16 0

LETTMANN JASON

  • Director
  • 10% Owner
0 2017-06-20 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
0 2017-06-20 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
No longer subject to file 2017-06-16 0

NOVO A/S

  • 10% Owner
No longer subject to file 2016-10-31 0

MORGENTHALER VENTURE PARTNERS IX LP

MORGENTHALER MANAGEMENT PARTNERS IX, LLC

  • 10% Owner
2,745,846 2016-10-31 0

KERINS PATRICK J

  • 10% Owner
3,490,073 2016-10-31 0

BASKETT FOREST

  • 10% Owner
3,490,073 2016-10-31 0

BARRIS PETER J

  • 10% Owner
3,490,073 2016-10-31 0

BARRETT M JAMES

  • 10% Owner
3,490,073 2016-10-31 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
3,490,073 2016-10-31 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

VISWANATHAN RAVI

  • 10% Owner
3,490,073 2016-10-31 0

SANDELL SCOTT D

  • 10% Owner
3,490,073 2016-10-31 0

MOTT DAVID M

  • 10% Owner
3,490,073 2016-10-31 0

KOLLURI KRISHNA KITTU

  • 10% Owner
3,490,073 2016-10-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments